Question 1

What is Robert I. Blum?

Accepted Answer

Robert I. Blum is a Person.

Question 2

How often does Robert I. Blum appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 20 articles.

Question 3

When was Robert I. Blum first tracked by Ergen?

Accepted Answer

First tracked on Oct 31, 2025.

Question 4

When was Robert I. Blum last mentioned in news?

Accepted Answer

Last active on Dec 09, 2025.

Question 5

What is Robert I. Blum's current news sentiment?

Accepted Answer

Aggregate sentiment score: -40 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Robert I. Blum in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Robert I. Blum?

Accepted Answer

Grabar Law Office Investigates Multiple Companies (Oct 31, 2025, 20 articles).

Question 8

How did the "Grabar Law Office Investigates Multiple Companies" event impact Robert I. Blum?

Accepted Answer

Robert I. Blum, CEO of Cytokinetics, acknowledged the company's decision to submit the NDA for aficamten without a REMS despite prior discussions with the FDA, contributing to the shareholder investigation.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.